Application Review Schedule for SHINE Medical Technologies LLC
SHINE Medical Technologies, LLC submitted an application for a construction permit to build a medical radioisotope production facility. The following table summarizes the U.S. Nuclear Regulatory Commission’s key milestones for reviewing this application.
Key Milestones | Completion Date Actual—A Target—T |
---|---|
Application Tendered | |
Receipt of Environmental Report (Part One of Two-Part Construction Permit Application)
|
03/2013—A |
Receipt of Preliminary Safety Analysis Report (Part Two of Two-Part Construction Permit Application)
|
05/2013—A |
Acceptance Review | |
Acceptance of Part One of Application for Docketing
|
07/2013—A |
Acceptance of Part Two of Application for Docketing
|
12/2013—A |
Environmental Review Schedule | |
Environmental Scoping Meeting
|
07/2013—A |
Environmental Site Audit
|
08/2013—A |
Issuance of Request for Additional Information on Environmental Report
|
08/2013—A |
Issuance of Supplemental Requests for Additional Information on Environmental Report
|
09/2014–01/2015—A |
NUREG Publication of Draft Environmental Impact Statement
|
05/2015—A |
NUREG Publication of Final Environmental Impact Statement
|
10/2015—A |
Safety Review Schedule | |
Issuance of Request for Additional Information on Preliminary Safety Analysis Report
|
09/2014—A |
Issuance of Supplemental Requests for Additional Information on Preliminary Safety Analysis Report
|
01/2015—A 03/2015—A 04/2015—A 09/2015—A |
Advisory Committee on Reactor Safeguards Subcommittee Meetings
|
06/2015—A 08/2015—A 09/2015—A |
Completion of Draft Safety Evaluation Report
|
09/2015—A |
Advisory Committee on Reactor Safeguards Full Committee Meeting
|
10/2015—A |
Completion of Safety Evaluation Report
|
10/2015—A |
NUREG Publication of Safety Evaluation Report
|
08/2016—A |
Hearing | |
Mandatory Hearing on Construction Permit Application
|
12/2015—A |
License | |
Decision on Construction Permit
|
02/2016—A |
Page Last Reviewed/Updated Wednesday, March 02, 2022
Page Last Reviewed/Updated Wednesday, March 02, 2022